Nithsdale schizophrenia surveys 23: Movement disorders. 20-Year review

British Journal of Psychiatry

Volumn 181, Issue NOV., 2002, Pages 422-427

  Halliday, Jennifer ^a   Farrington, Susan ^a   Macdonald, Shiona ^a   MacEwan, Tom ^a   Sharkey, Val ^a   McCreadie, Robin ^a  

^a Crichton Royal Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DROPERIDOL; FLUPENTIXOL; FLUPENTIXOL DECANOATE; FLUPHENAZINE DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL DECANOATE;

ADULT; AGED; AKATHISIA; ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INVOLUNTARY MOVEMENT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; PARKINSONISM; PREVALENCE; PSYCHOSIS; RATING SCALE; RISK ASSESSMENT; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA; UNITED KINGDOM;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PREVALENCE; RISK FACTORS; SCHIZOPHRENIA; SCOTLAND;

EID: 0036849123     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.181.5.422     Document Type: Article

References (25)

1. Baldessarini, R. J. (1980) Drugs and the treatment of psychiatric disorders. In The Pharmacological Basis of Therapeutics, 6th Edn (eds A. G. Gilman, L. S. Goodman & A. Gilman), p. 397. New York: Macmillan.
2. Barnes,T. R. E. (1989) A rating scale for drug-induced akathisia. British Journal of Pschiatry, 154, 672-676.
3. Bergen, J. A., Eyland, E. A., Campbell, J. A., et al (1989) The course of tardive dyskinesia in patients on long term neuroleptics. British Journal of Psychiatry, 154, 523-528.
4. Casey, D. E. (1995) Neuroleptic-induced extrapyramidal syndromes and tardive dyskinesia. In Schizophrenia (eds S. R. Hirsch & D. R. Weinberger), pp. 546-565. Oxford: Blackwell.
5. Fenton, W. S. (2000) Prevalence of spontaneous dyskinesia in schizophrenia. Journal of Clinical Psychiatry, 61 (suppl. 4), 10-14.
6. Geddes, J., Freemantle, N., Harrison, P., et al (2000) Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis. BMJ, 321, 1371-1376.
7. Kane, J. M., Jeste, D. V., Barnes, T. R. E., et al (1992) Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association.
8. Kay, S., Fishbein, A. & Opler, L. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-275.
9. Kelly, C., McCreadie, R. G., MacEwan, T., et al (1998) Nithsdale schizophrenia surveys, 17: Fifteen year review. British Journal of Psychiatry, 172, 513-517.
10. _ & _ (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry, 156, 1751-1757.
11. Leung, A. & Chue, P. (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica, 101 (suppl. 401), 3-38.
12. Liddle, P. F., Barnes, T. R. E., Speller, J., et al (1993) Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia. British Journal of Psychiatry, 163, 776-780.
13. McCreadie, R. G. (1982) The Nithsdale schizophrenia survey I: Psychiatric and social handicaps. British Journal of Psychiatry, 140, 582-586.
14. _, Barron, E. T. & Winslow, G. S. (1982) The Nithsdale schizophrenia survey. II. Abnormal movements. British Journal of Psychiatry, 140, S87-590.
15. _, Robertson, L. J. & Wiles, D. H. (1992) The Nithsdale schizophrenia surveys. IX: Akathisia. Parkinsonism, tardive dyskinesia and plasma neuroleptic levels. British Journal of Psychiatry, 160, 793-799.
16. McGuffin, P., Farmer, A. E. & Harvey, I. (1991) A polydiagnostic application of operational criteria in studies of psychotic illness: Development and reliability of the OPCRIT system. Archives of General Psychiatry, 48, 764-770.
17. Modestin, J., Stephan, P. L., Erni, T., et al (2000) Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia. Schizophrenia Research, 42, 223-230.
18. Schooler, N. R. & Kane, J. M. (1982) Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486-487.
19. Simpson, G. M. & Angus, J. W. (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, 11-19.
20. US Department of Health, Education and Welfare (1976) Abnormal involuntary movement scale (AIMS). In ECDEU Assessment Manual (ed. W. Guy). Rockville, MD: US Department of Health, Education and Welfare.
21. van Harten, P. N., Matroos, G. E., Hoek, H. W., et al (1996) The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia. The Curacao Extrapyramidal Syndromes Study I. Schizophrenia Research, 19, 195-203.
22. _, Hoek, H. W., Matroos, G. E., et al (1998) Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curacao Extrapyramidal Syndromes Study III. American Journal of Psychiatry, 155, 565-567.
23. Waldron, G., Chalmers, J., Bone, A., et al (1995) Health and Lifestyle in Dumfries and Galloway in 1995. Dumfries: Dumfries and Galloway Health Board.
24. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO.
25. Yassa, R. & Jeste, D. V. (1992) Gender differences in tardive dyskinesia: A critical review of the literature. Schizophrenia Bulletin, 18, 701-715.